Masters of Science Degree in Clinical Investigation for Board-Eligible Clinicians
The NYU School of Medicine Clinical and Translational Science Institute is proud to offer a Masters of Science degree in Clinical Investigation. The MSCI degree is intended for physicians and other post-doctoral level clinicians and clinical investigators interested in gaining the knowledge and research experience necessary to build their careers.
Trainees can pursue a MSCI with a concentration in Translational Medicine, Health Innovations and Therapeutics (HIT) or a concentration in Comparative Effectiveness Research. All three programs include an ongoing requirement to actively carry on a translational or clinical research project, and place an emphasis on career development, productivity and mentoring support.
ABOUT THE TRANSLATIONAL MEDICINE TRACK
The rapid strides and advancement of biomedical discoveries present an opportunity for clinical care to further improve upon disease prevention, diagnosis, and management. The goal of this training program is to train clinician-scientists in the skills necessary to translate scientific discoveries to clinical settings, to determine the efficacy and outcomes of new and established therapy and identify, using epidemiologic and statistical tools, the health problems of the future. The program is intended for persons who have completed residency training in a clinical department.
ABOUT THE HEALTH INNOVATIONS AND THERAPEUTICS TRACK
The ability to translate knowledge into better patient health outcomes has become a major thrust of medical research. The ability to bring new ideas into use requires creative partnerships between the laboratory, the clinic, and the private sector companies that develop and disseminate new products based on the fruits of scientific research. A basic understanding of these interactions is now essential for all investigators, but for those investigators interested in seeing discoveries implemented it is even more important that they receive training in fields such as drug and device development, the workings of industry and the processes of academic/private collaboration. This concentration shares most of the elements of our Translational Medicine track, but will add additional training in drug and device development, and the processes through which new products can be brought to clinical use.
ABOUT THE COMPARATIVE EFFECTIVENESS TRACK
Comparative Effectiveness Research focuses on assessing the relative effectiveness of two or more therapeutic options in real-world populations. Accordingly, the MSCI in Comparative Effectiveness Research provides additional training in epidemiologic and methodologic strategies for assessing real-world outcomes. The MSCI with a concentration in Comparative Effectiveness Research shares courses with the MSCI in Translational Research but is administered by the Department of Population Health: follow this link for more information.
To contact us about the Masters of Science in Clinical Investigation program, please email us at firstname.lastname@example.org
Investigators planning to apply for NYU/HHC CTSI support should be aware that it is a requirement that all publications or media resulting from the utilization of its resources credit the CTSI grant by including the NIH Funding acknowledgment and complying with NIH Public Access Policy.